Mergin 0.125mg Injection
₹18.04*
MRP ₹20.5
12% off
(Inclusive of all Taxes)
GetFREE deliveryon this order with circle membership
Provide Delivery Location
Mergin 0.125mg Injection belongs to the class of medication called 'ergot alkaloids' or 'uterotonic' primarily used to prevent and stop heavy bleeding (postpartum-third stage of labour bleeding) after childbirth or after a miscarriage in cesarean section. Besides this, it is also used to improve uterine contraction (antepartum) and produce uterine contraction during the third stage of labor (postpartum). Postpartum haemorrhage is heavy bleeding (more than normal) after the birth of the baby.
Mergin 0.125mg Injection contains a semi-synthetic ergot alkaloid 'Methylergometrine', that stimulates uterine muscles and increases the uterus' contractions, thus reducing blood loss. It also increases the effects of a natural substance called prostaglandins (PGs), increasing contractions and producing labour. As a result, these increased uterine contractions help in the child's delivery and substantially reduce excessive uterine bleeding.
Mergin 0.125mg Injection will be administered by a healthcare professional. Do not self-administer. The most common side effects of Mergin 0.125mg Injection are nausea, vomiting, stomach pain, and mild headache in some cases. Most of these side effects of Mergin 0.125mg Injection do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
If you ever had surgery on the uterus, cesarean, or premature labour, please inform your doctor to avoid any complications. If you have been given prostaglandins, then do not take Mergin 0.125mg Injection; if both medicines are taken together, it can increase the contractions. Mergin 0.125mg Injection should not be used for a prolonged time if the contractions do not increase or have severe pre-eclamptic toxemia (high blood pressure, protein in the urine, and swelling), blood or heart circulation problem.
Mergin 0.125mg Injection contains a semi-synthetic ergot alkaloid 'Methylergometrine' primarily used to stop heavy bleeding postpartum, i.e. third stage of labour bleeding after childbirth or after a miscarriage in cesarean section. Additionally, it plays a significant role in birth by increasing uterus contractions and inducing labour in pregnant women. Mergin 0.125mg Injection works by stimulating uterine muscles and expanding the uterus' contractions, thus reducing blood loss. It also increases the effects of a natural substance called prostaglandins (PGs), increases the contraction,s and hence induces labour. As a result, these increased uterine contractions help deliver the child and substantially reduce excessive uterine bleeding.
Do not take Mergin 0.125mg Injection if you are allergic to Mergin 0.125mg Injection or any of its ingredients. Increasing the dose of Mergin 0.125mg Injection can be harmful if your womb already has too strong contractions, any obstructions in the pathway that might prevent the delivery or if the baby is not receiving a sufficient oxygen supply. Also, the use of Mergin 0.125mg Injection is not advisable if the baby is wrongly positioned in the birth canal, the baby’s head is too large to fit through the pelvis, the placenta lies near the neck of the womb, the placenta separates from the womb before birth, the womb is over-extended and likely to tear (in case you are carrying more than one baby). If you have been given prostaglandins, do not use Mergin 0.125mg Injection within 6 hours as both medications, if taken together, can increase the contractions. Mergin 0.125mg Injection should not be used for a prolonged time if the contractions do not increase or if you have severe pre-eclamptic toxaemia (high blood pressure, protein in the urine, and swelling) or blood or heart circulation problems.
Drug-Drug Interaction: Mergin 0.125mg Injection may interact with anaesthetics (sevoflurane, halothane, cyclopropane, desflurane), other medicines used to start labour (prostaglandins), anti-diuretic hormone (vasopressin), a neurotransmitter (dopamine), anti-sickness medicine (ondansetron), sympathomimetic agents (epinephrine).
Drug-Food Interaction: Grapefruit juice intake should be avoided with Mergin 0.125mg Injection as it may interact with Mergin 0.125mg Injection to produce unpleasant side effects.
Drug-Disease Interaction: Mergin 0.125mg Injection should not be given to patients with previous cesarean section, hypertension (high blood pressure), heart problem, cervical cancer, herpes infection, kidney problem, if you are more than 40 weeks pregnant or are more than 35 years age, the pelvis is too small for normal delivery.
Mergin 0.125mg Injection when given for induction of labor, stimulation of labor and prevention of vaginal bleeding after delivery of the baby especially after caesarean surgery. It must be administered only by the intravenous (IV) or intramuscular (IM) route under medical supervision in a hospital setting only.
Postpartum haemorrhage: It is a serious but rare condition which causes excessive vaginal bleeding within one day after giving birth to the child. It happens mostly in cases of cesarean birth. When a baby is delivered, the uterus of the body contracts and forces out the placenta. After the placenta's delivery, these contractions put pressure on the bleeding vessels at the place where the placenta was attached, resulting in vaginal bleeding. It is normal to lose some amount of blood after delivery, but if a woman is losing more blood than normal, it can be dangerous.
Alcohol
Unsafe
It is not known if alcohol affects Mergin 0.125mg Injection. Consult your doctor.
Pregnancy
Unsafe
Mergin 0.125mg Injection is not recommended for use during pregnancy.
Breast Feeding
Unsafe
It is advised to avoid breastfeeding for at least 12 hours after taking Mergin 0.125mg Injection as this medicine may pass into breast milk and can harm a nursing baby.
Driving
Unsafe
Avoid driving and operating machinery.
Liver
Safe if prescribed
Mergin 0.125mg Injection is not known to show any interaction in liver disease.
Kidney
Caution
Mergin 0.125mg Injection to be taken with caution, especially if you have a history of kidney diseases/conditions. The dose will be adjusted by your doctor.
Children
Unsafe
Mergin 0.125mg Injection is not recommended for children below the age of 18 years. The safety and effectiveness of Mergin 0.125mg Injection have not been established in children.
Country of origin
We provide you with authentic, trustworthy and relevant information
Product Substitutes